# Syndax Pharmaceuticals Inc > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:c29e922d-55a3-4a61-b1ae-27c410dade6e | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/syndax-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 20 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-18T07:12:02.527648+00:00 | | Last reviewed | 2026-10-18T07:12:02.527648+00:00 | ## Identity - Legal name: Syndax Pharmaceuticals Inc - Display name: Syndax Pharmaceuticals Inc ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T03:07:08.308257+00:00 | | Completeness | 0.364 | | Record Quality | 0.827 | | Directors | 10 | | Committees | 0 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Aleksandra Rizo: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:6 - Jennifer Jarrett: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:8 - Keith A. Katkin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:9 - Martin H. Huber: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:10 - Pierre Legault: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:13 - William Meury: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:14 - Aleksandra Rizo, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:7 - Dennis G. Podlesak: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:5 - Martin H. Huber, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:11 - Michael A. Metzger: Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:12 ## Executive leadership - Nick Botwood: Head of Research and Development, Chief Medical Officer. Status: current. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:18 - Keith A. Goldan: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:15 - Luke J. Albrecht: General Counsel and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:16 - Michael A. Metzger: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:17 - Nick Botwood, M.B.B.S.: Head of Research and Development, Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:19 - Steve Closter: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:20 ## Governance events - DIRECTOR_APPOINTED: William Meury seat on Syndax Pharmaceuticals Inc, effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:dvs0abit5h0x - EXECUTIVE_APPOINTED: Nick Botwood executive of Syndax Pharmaceuticals Inc, effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1wheh4ltqrxq5 - DIRECTOR_APPOINTED: Aleksandra Rizo seat on Syndax Pharmaceuticals Inc, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:nlmhrr1b53dyj - DIRECTOR_APPOINTED: Martin H. Huber seat on Syndax Pharmaceuticals Inc, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:17ny3811pld14x - DIRECTOR_APPOINTED: Jennifer Jarrett seat on Syndax Pharmaceuticals Inc, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:6yr2tg1sp3fs6 - DIRECTOR_APPOINTED: Keith A. Katkin seat on Syndax Pharmaceuticals Inc, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:10ccp32lbdxvc - DIRECTOR_APPOINTED: Pierre Legault seat on Syndax Pharmaceuticals Inc, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1136wdz13ept3 ## Scoped resources - `alpha://company/syndax-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record - `alpha://company/syndax-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/syndax-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/syndax-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=board - `alpha://company/syndax-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/syndax-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/syndax-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/syndax-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/syndax-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/syndax-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/syndax-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/syndax-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/syndax-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/syndax-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/syndax-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/syndax-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/syndax-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/syndax-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/syndax-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/syndax-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=events - `alpha://company/syndax-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/syndax-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/syndax-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Dennis G. Podlesak: Chairman of the Board. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Aleksandra Rizo: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:6. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7. - Aleksandra Rizo, M.D., Ph.D.: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Jennifer Jarrett: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7. - Keith A. Katkin: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7. - Martin H. Huber: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7. - Martin H. Huber, M.D.: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Michael A. Metzger: Chief Executive Officer and Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Pierre Legault: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:13. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7. - William Meury: Director. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:14. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7. - Keith A. Goldan: Chief Financial Officer. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Luke J. Albrecht: General Counsel and Secretary. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Michael A. Metzger: Chief Executive Officer. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Nick Botwood: Head of Research and Development, Chief Medical Officer. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:18. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c1b0ae41241665092f1ad3b4d122a3d319851cb8df563cf526dc44438c84cdcb. - Nick Botwood, M.B.B.S.: Head of Research and Development, Chief Medical Officer. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. - Steve Closter: Chief Commercial Officer. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Syndax Pharmaceuticals Inc. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f6f680e6043233a3b6554033d7fb7670e821891afd6bcc6bc9f27bdd9d8b3e3. ## Entity Status - Public listing published. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f6f680e6043233a3b6554033d7fb7670e821891afd6bcc6bc9f27bdd9d8b3e3. ## Published Fact - US. Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f6f680e6043233a3b6554033d7fb7670e821891afd6bcc6bc9f27bdd9d8b3e3. ## Security Listing - SNDX (NASDAQ). Claim: alpha:claim:company:c29e922d-55a3-4a61-b1ae-27c410dade6e:security_listing:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1f6f680e6043233a3b6554033d7fb7670e821891afd6bcc6bc9f27bdd9d8b3e3. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:1f6f680e6043233a3b6554033d7fb7670e821891afd6bcc6bc9f27bdd9d8b3e3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc). - alpha:projection-evidence:document:d2906deca37feb88adaadc938b921bb876737810cf3929c9207c2fb17505b959: [SEC DEF 14A 0001193125-26-197859](https://www.sec.gov/Archives/edgar/data/1395937/000119312526197859/sndx-20260430.htm). - alpha:projection-evidence:document:1d19ad24b50ebe98e7f050957db59f5ec69b114a3e2aab2d4e1bb5bd4e4f22a7: [DEF 14A sndx-20260430.htm](https://www.sec.gov/Archives/edgar/data/1395937/000119312526197859/sndx-20260430.htm). - alpha:projection-evidence:document:c1b0ae41241665092f1ad3b4d122a3d319851cb8df563cf526dc44438c84cdcb: [SNDX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1395937/000119312526197859/sndx-20260430.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/syndax-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/syndax-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/syndax-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/syndax-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T03:07:07.948079+00:00; recorded 2026-10-19T03:07:07.948079+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.